Mosseri Marlio Charles 13D/13G Filings for Nuvectis Pharma, Inc. (NVCT)

Mosseri Marlio Charles 13D and 13G filings for Nuvectis Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-28
08:37 am
Purchase		 2023-12-31 13G Nuvectis Pharma, Inc.
NVCT		 Mosseri Marlio Charles 2,595,000
15.000%		 214,824increase
(+9.03%)		 Filing
2023-01-09
10:19 am
Purchase		 2022-12-30 13G Nuvectis Pharma, Inc.
NVCT		 Mosseri Marlio Charles 2,380,176
16.300%		 977,620increase
(+69.70%)		 Filing
2022-03-28
6:46 pm
Purchase		 2022-03-22 13G Nuvectis Pharma, Inc.
NVCT		 Mosseri Marlio Charles 1,402,556
11.030%		 1,402,556increase
(New Position)		 Filing